The bladder cancer section is a comprehensive resource for urology news and expert insights. Read more at Urology Times.

The prostate cancer section is a comprehensive resource for urology news and expert insights. Read more at Urology Times.

June 25th 2025 Oral sulopenem was approved by the FDA in October 2024 for the management of uUTIs.

A panelist discusses how benign prostatic hyperplasia (BPH) treatment has evolved to include a spectrum of minimally invasive and surgical interventions, ranging from emerging technologies like ...

Prostate Cancer Awareness: Not Just a Month Prostate cancer awareness isn’t just about blue ribbons in September. As I’ve often said, “Cancer doesn’t take a holiday or a weekend.” Prostate cancer ...

First-line nivolumab (Opdivo) plus ipilimumab (Yervoy) continued to show improved survival and durable response benefits vs sunitinib (Sutent) in patients with previously untreated advanced renal cell ...

Key Takeaways Sasanlimab combined with BCG improved event-free survival in high-risk NMIBC patients, particularly those with CIS and T1 tumors. Subgroup analyses showed EFS benefits across different ...

Physician Summary: Real-World Data on Nadofaragene Firadenovec in BCG-Unresponsive NMIBC A recent study by Moyer et al (2025) provides real-world data on the efficacy and safety of nadofaragene ...

Key Takeaways The FDA will evaluate talazoparib and enzalutamide for mCRPC patients unselected for HRR gene alterations, expanding beyond HRR-positive cases. TALAPRO-2 trial data showed significant ...

Key Takeaways UGN-102's NDA is supported by the phase 3 ENVISION trial, showing a 79.6% complete response rate at 3 months for LG-IR-NMIBC patients. The FDA is evaluating if the observed duration of ...

In 2025, cytoreductive nephrectomy (CN) remains an integral part of the multidisciplinary management of metastatic renal cell carcinoma (mRCC). Rapid advances in systemic therapies—particularly immune ...

Key Takeaways The AUSCO trial showed a 94% success rate in achieving significant continence improvement in men with SUI using the artificial urinary sphincter. The study found no device infections and ...